Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
PLoS One. 2012;7(3):e32921. doi: 10.1371/journal.pone.0032921. Epub 2012 Mar 5.
Wnt7a is known to be a tumor suppressor that is lost in NSCLC, but no mechanism of loss has been established. Methylation of promoter regions has been established as a common mechanism of loss of tumor suppressor expression in NSCLC. We previously demonstrated that loss of Wnt7a in non-transformed lung epithelial cell lines led to increased cell growth, altered 3-D culture growth, and increased migration. The Wnt7a promoter has a higher percentage of methylation in NSCLC tumor tissue compared to matched normal lung tissue and methylation of the promoter region leads to decreased activity. We treated H157 and H1299 NSCLC cell lines with 5-Aza-2'-deoxycytidine and detected loss of Wnt7a promoter methylation, increased Wnt7a expression, and increased activity of the Wnt7a lung signaling pathway. When DNMT1 expression was knocked down by shRNA, expression of Wnt7a increased and methylation decreased. Together these data suggest that in NSCLC, Wnt7a is lost by methylation in a subset of tumors and that this methylation is maintained by DNMT1. Restoration of Wnt7a expression through demethylation could be an important therapeutic approach in the treatment of NSCLC.
Wnt7a 是一种已知的肿瘤抑制因子,在 NSCLC 中丢失,但尚未确定丢失的机制。启动子区域的甲基化已被确立为 NSCLC 中肿瘤抑制因子表达丢失的常见机制。我们之前证明,非转化肺上皮细胞系中 Wnt7a 的丢失导致细胞生长增加、三维培养生长改变和迁移增加。与匹配的正常肺组织相比,Wnt7a 启动子在 NSCLC 肿瘤组织中的甲基化百分比更高,启动子区域的甲基化导致活性降低。我们用 5-Aza-2'-脱氧胞苷处理 H157 和 H1299 NSCLC 细胞系,检测到 Wnt7a 启动子甲基化的丢失、Wnt7a 表达的增加和 Wnt7a 肺信号通路活性的增加。当通过 shRNA 敲低 DNMT1 表达时,Wnt7a 的表达增加,甲基化减少。这些数据表明,在 NSCLC 中,Wnt7a 被一组肿瘤中的甲基化丢失,并且这种甲基化由 DNMT1 维持。通过去甲基化恢复 Wnt7a 表达可能是治疗 NSCLC 的重要治疗方法。